VANCOUVER, British Columbia, May 06, 2024 (Korea Bizwire) – Today marks a pivotal development for Brains Bioceutical Corp (“Brains Bio”), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, a distinguished figure in animal health with profound experience from his tenures at Pfizer Animal Health and Zoetis. His arrival [...]
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well tolerated following intravitreal administration of single and multiple doses, meeting its primary safety endpoints and showed [...]
RIYADH, Saudi Arabia, May 02, 2024 (Korea Bizwire) – KFSH&RC tops the healthcare sector in the Kingdom of Saudi Arabia and the Middle East, recognizing it as the most valuable healthcare brand in these regions for the second year. According to the 2024 Brand Finance reports, it placed 9th in Saudi Arabia and 28th in the Middle [...]
April 30, 2024 (Korea Bizwire) Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands, and Miami, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nicklaus Children’s Health System, a nationally recognized leader in pediatric [...]
All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for election confirmed Mathai Mammen, Graeme Pitkethly and Michael Rechsteiner elected as new Board members Dividend of CHF 0.45 per registered dividend-paying share approved, representing 24% of core net income Basel, April 30, 2024 – [...]
VANCOUVER, British Columbia, April 30, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management [...]
Over 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, immunotherapy, and immune modulators will converge at the largest allergy and immunology congress. The congress will occur from 31 May to 3 June in Valencia, Spain. [...]
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement clears path for launch of Jubbonti® and Wyost® on May 31, 2025 or earlier under certain circumstances Jubbonti® and Wyost® are first and only FDA-approved biosimilars to and interchangeable with Prolia*® and [...]
April 29, 2024 (Korea Bizwire) First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics litigation settlement reached in the US (provision recognized of EUR 982 million) Income from operations EUR -824 million, including above provision Adjusted EBITA [...]
World Veterinary Day 2024 celebrates the essential work of veterinarians, yet new data show only 49% of veterinary professionals believe their profession is appreciated. Veterinary associations and Boehringer Ingelheim unite to help address this issue—starting with showcasing often-unseen aspects of the veterinary profession. The World Veterinary Association’s theme for World Veterinary Day this year (April [...]